News
Watch
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Health Systems|

Pharmacy Technician|

Soumar Haddad, PharmD Candidate

Articles by Soumar Haddad, PharmD Candidate

Multiple myeloma cells -- Image credit: Saiful52 | stock.adobe.com

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

ByAmir Ali, PharmD, BCOP,Kevin Le, PharmD, BCOP,Tanjia Toma, PharmD Candidate,Soumar Haddad, PharmD Candidate,Fleuri Dindar, PharmD Candidate,Bryan Ceballos, PharmD Candidate

December 26th 2024

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Latest Updated Articles

Trending on Pharmacy Times

Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC

Could CAR T Therapy Become Adjustable After Infusion?